top of page
Home
Calvine Healthcare
Calvine Sustainables
Equity Research
Basilea
Blog
Contact
Use tab to navigate through the menu items.
All Posts
Search
Brian White
Jan 11, 2021
Basilea preliminary 2020 revenue and portfolio progress
Andrew Keith
Dec 21, 2020
Basilea's derazantinib - a differentiated FGFR inhibitor
Andrew Keith
Dec 7, 2020
Diurnal Group and Spruce Biosciences
Andrew Keith
Nov 13, 2020
Diurnal Group - Positive initial signs in the US for Alkindi
Andrew Keith
Nov 11, 2020
Diurnal Group - Unveiling DITEST
Andrew Keith
Oct 19, 2020
Introducing Basilea Pharmaceutica
Andrew Keith
Oct 9, 2020
Diurnal Group - Spruce Biosciences
bottom of page
